G. Bhat

Antisense Inhibition of S6 Kinase 1 Produces Improved Glucose Tolerance and Is Well Tolerated for 4 Weeks of Treatment in Rats

G. Alton, J. Heyen, B. Hirakawa, 2010, Pharmacology.

Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.

A. Chugh, V. Jain, K. Mookhtiar, 2017, European journal of medicinal chemistry.

The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.

A. Fanjul, P. Rejto, G. Paderes, 2010, Bioorganic & medicinal chemistry letters.

Discovery of 5-(3,4-Difluorophenyl)-3-(pyrazol-4-yl)-7-azaindole (GNF3809) for β-Cell Survival in Type 1 Diabetes

Matthew S. Tremblay, Shanshan Yan, B. Laffitte, 2019, ACS Omega.

Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and Depression.

A. Chugh, S. Chaudhary, D. Barawkar, 2017, ACS medicinal chemistry letters.

Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation.

S. Menon, S. Chaudhary, D. Barawkar, 2017, Journal of medicinal chemistry.